Amiloidózis: vizsgálatok itt: Dánia

In Dánia 16 Also abroad 184

16 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Where
Aarhus N, Copenhagen Oe
Életkor
18 év to 90 év
People
1200 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00
3. fázisCsak meghívásos
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Aarhus N, København Ø, Odense C
Életkor
18 év and over
People
700 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06679946
3. fázisTaking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Aarhus, Copenhagen, Odense C
Életkor
18 év and over
People
1280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
3. fázisTaking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Aarhus N, Copenhagen Oe, Odense C
Életkor
18 év to 85 év
People
1750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
No phaseTaking people
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Where
Aarhus, Copenhagen
People
1500 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT04561518
No phaseTaking people
A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
Where
Multiple Locations
Életkor
18 év and over
People
2000 worldwide
Run by
Bayer
See details and how to joinNCT07235462
No phaseTaking people
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Where
Horsens
People
52 121 worldwide
Run by
AstraZeneca
See details and how to joinNCT06355934
3. fázisNot yet taking people in Dánia
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Where
Aarhus, Odense C
People
1180 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00
3. fázisNot yet taking people in Dánia
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Where
Aarhus N
Életkor
18 év and over
People
250 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07116473 · EU 2024-513676-18-00
3. fázisTaking people
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Where
Aarhus N
Életkor
18 év to 75 év
People
587 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00
4. fázisTaking people
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Where
Aarhus N
Életkor
18 év to 80 év
People
150 worldwide
Run by
Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07695701 · EU 2026-526068-19-00
1/2. fázisTaking people
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Where
Aarhus
Életkor
65 év and over
People
15
Run by
Steen Hvitfeldt Poulsen
See details and how to joinNCT06318260
3. fázisCsak meghívásos
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Where
Copenhagen
Életkor
18 év and over
People
1400 worldwide
Run by
Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493
No phaseTaking people
CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Where
Copenhagen
Életkor
65 év and over
People
300
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07435168
No phaseNot yet taking people in Dánia
Increased Pacemaker Lower Rate in ATTR Cardiac Amyloidosis
Where
Aarhus, Copenhagen
Életkor
18 év and over
People
34 worldwide
Run by
Region Skane
See details and how to joinNCT07413081
No phaseTaking people
Phenotyping and Characterization of wtATTR-CM (TRACE 1)
Where
Aarhus
Életkor
18 év and over
People
120
Run by
Steen Hvitfeldt Poulsen
See details and how to joinNCT06291805